GR3020902T3 - Use of 15-keto-prostaglandin compound for improvement of encephalic function - Google Patents
Use of 15-keto-prostaglandin compound for improvement of encephalic functionInfo
- Publication number
- GR3020902T3 GR3020902T3 GR960402122T GR960402122T GR3020902T3 GR 3020902 T3 GR3020902 T3 GR 3020902T3 GR 960402122 T GR960402122 T GR 960402122T GR 960402122 T GR960402122 T GR 960402122T GR 3020902 T3 GR3020902 T3 GR 3020902T3
- Authority
- GR
- Greece
- Prior art keywords
- keto
- improvement
- prostaglandin compound
- encephalic
- function
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30383989 | 1989-11-22 | ||
JP761190 | 1990-01-17 | ||
JP8543990A JPH07116135B2 (ja) | 1990-03-30 | 1990-03-30 | 6,15―ジケト―5―ハロプロスタグランジンe類 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3020902T3 true GR3020902T3 (en) | 1996-11-30 |
Family
ID=27277677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960402122T GR3020902T3 (en) | 1989-11-22 | 1996-08-29 | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
Country Status (9)
Country | Link |
---|---|
US (3) | US5117042A (el) |
EP (1) | EP0435443B1 (el) |
KR (2) | KR0147057B1 (el) |
AT (1) | ATE141793T1 (el) |
CA (1) | CA2030345C (el) |
DE (1) | DE69028289T2 (el) |
DK (1) | DK0435443T3 (el) |
ES (1) | ES2093636T3 (el) |
GR (1) | GR3020902T3 (el) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2851704B2 (ja) * | 1993-02-03 | 1999-01-27 | 帝人株式会社 | 脳血栓症治療のための薬学的組成物 |
HU223345B1 (hu) | 1995-12-20 | 2004-08-30 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára |
DK0857718T3 (da) * | 1996-06-10 | 2002-12-16 | Sucampo Ag | Endothelinantagonist |
US6680339B2 (en) | 1996-11-12 | 2004-01-20 | Alcon Manufacturing, Ltd. | 15-fluoro prostaglandins as ocular hypotensives |
JP4248022B2 (ja) | 1996-11-12 | 2009-04-02 | アルコン ラボラトリーズ,インコーポレイテッド | 眼圧降下剤としての15―フルオロプロスタグランジン |
PL339212A1 (en) * | 1997-09-09 | 2000-12-04 | Procter & Gamble | Aromatic c16-c20-substituted tetrahydroprostaglandines useful as fp agonists |
SK3382000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders |
PT978284E (pt) * | 1997-11-28 | 2008-10-07 | Sucampo Ag | Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina |
JP4834224B2 (ja) | 1999-03-05 | 2011-12-14 | デューク ユニバーシティ | C16不飽和fp−選択的プロスタグランジン類縁体 |
AR026046A1 (es) | 1999-10-15 | 2002-12-26 | R Tech Ueno Ltd | NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA |
NZ521464A (en) | 2000-03-24 | 2004-09-24 | Sucampo Ag | Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
US20020172693A1 (en) * | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
TWI331920B (en) | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
TWI263505B (en) * | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
ES2375082T3 (es) | 2005-01-27 | 2012-02-24 | Sucampo Ag | Composición para el tratamiento de trastornos del sistema nervioso central. |
US20060281818A1 (en) * | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
US8513441B2 (en) * | 2008-08-29 | 2013-08-20 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
WO2010083597A1 (en) | 2009-01-22 | 2010-07-29 | Apotex Pharmachem Inc. | Methods of making lubiprostone and intermediates thereof |
US8592483B2 (en) | 2011-08-05 | 2013-11-26 | Sucampo Ag | Method for treating schizophrenia |
CN104140410B (zh) * | 2013-05-09 | 2017-12-15 | 江苏豪森药业集团有限公司 | 鲁比前列酮的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153858A3 (en) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | The therapeutic use of prostaglandins |
JPS62198616A (ja) * | 1986-02-24 | 1987-09-02 | Res Dev Corp Of Japan | 脳血流量改善・脳細胞保護剤 |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ES2038289T3 (es) * | 1987-05-15 | 1993-07-16 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. |
ATE82499T1 (de) * | 1987-09-18 | 1992-12-15 | R Tech Ueno Ltd | Okulare hypotensivagenzien. |
DE3873007T2 (de) * | 1987-10-02 | 1992-12-03 | Ueno Seiyaku Oyo Kenkyujo Kk | Kathartica. |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
EP0343904B1 (en) * | 1988-05-23 | 1993-04-28 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Hypersphyxia causing composition |
US5106809A (en) * | 1990-12-14 | 1992-04-21 | Exxon Research And Engineering Company | High activity, high yield tin modified platinum-iridium catalysts, and reforming process utilizing such catalysts |
-
1990
- 1990-11-20 CA CA002030345A patent/CA2030345C/en not_active Expired - Lifetime
- 1990-11-21 AT AT90312642T patent/ATE141793T1/de not_active IP Right Cessation
- 1990-11-21 DK DK90312642.3T patent/DK0435443T3/da active
- 1990-11-21 ES ES90312642T patent/ES2093636T3/es not_active Expired - Lifetime
- 1990-11-21 DE DE69028289T patent/DE69028289T2/de not_active Expired - Lifetime
- 1990-11-21 EP EP90312642A patent/EP0435443B1/en not_active Expired - Lifetime
- 1990-11-21 US US07/616,960 patent/US5117042A/en not_active Expired - Lifetime
- 1990-11-22 KR KR1019900018959A patent/KR0147057B1/ko not_active IP Right Cessation
-
1991
- 1991-10-16 US US07/777,595 patent/US5290811A/en not_active Expired - Lifetime
-
1993
- 1993-10-29 US US08/142,968 patent/US5426115A/en not_active Expired - Lifetime
-
1996
- 1996-08-29 GR GR960402122T patent/GR3020902T3/el unknown
-
1998
- 1998-02-21 KR KR1019980005506A patent/KR0167745B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0435443A3 (en) | 1993-01-27 |
EP0435443B1 (en) | 1996-08-28 |
ES2093636T3 (es) | 1997-01-01 |
CA2030345A1 (en) | 1991-05-23 |
DE69028289D1 (de) | 1996-10-02 |
KR0147057B1 (ko) | 1998-08-17 |
EP0435443A2 (en) | 1991-07-03 |
US5117042A (en) | 1992-05-26 |
CA2030345C (en) | 1998-12-08 |
US5426115A (en) | 1995-06-20 |
ATE141793T1 (de) | 1996-09-15 |
DE69028289T2 (de) | 1997-01-09 |
US5290811A (en) | 1994-03-01 |
KR910009269A (ko) | 1991-06-28 |
DK0435443T3 (da) | 1996-09-16 |
KR0167745B1 (ko) | 1999-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3020902T3 (en) | Use of 15-keto-prostaglandin compound for improvement of encephalic function | |
GR3027666T3 (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
DE3865817D1 (el) | ||
DE3779053D1 (el) | ||
GB9003946D0 (en) | Difluoromethylene compounds | |
EP0455448A3 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
ES2093774T3 (es) | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. | |
EP0467564A3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
EP0411733A3 (en) | 11-beta-aryle-gona-4,9-dien-3-ones | |
GR3018674T3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
GR3026105T3 (en) | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds | |
EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
EP0405905A3 (en) | Use of isoxazolin-3-one derivatives as antidepressants | |
GR3022217T3 (en) | Treatment of cataract with prostacyclin compounds | |
EP0261439A3 (en) | Medicament for curing arteriosclerosis, comprising pyrimido (2,1-b) benzothiazole derivative | |
AR245225A1 (es) | Composiciones para el tratamiento de cuero. | |
EG19467A (en) | Self aspirating syringe. | |
UA11675A1 (uk) | 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ | |
DE3882331D1 (en) | Dose. | |
AR244676A1 (es) | Un procedimiento para la preparacion de ranitidina. | |
AR242719A1 (es) | Jeringa. | |
EP0432983A3 (en) | Novel compounds of the diterpene type | |
GB8925969D0 (en) | Vapouriser |